Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations

被引:7
|
作者
Roujeau, Jean-Claude [1 ]
机构
[1] UPEC, Dept Dermatol, F-92160 Creteil, France
关键词
drug hypersensitivity; epidermal necrolysis; erythema multiforme; Stevens-Johnson syndrome; REGULATORY T-CELLS; ERYTHEMA MULTIFORME; INTRAVENOUS IMMUNOGLOBULIN; CUTANEOUS REACTIONS; LYELL SYNDROME; SKIN-LESIONS; HLA-B; CARBAMAZEPINE; DISEASE; DRUGS;
D O I
10.1016/j.dsi.2013.09.009
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To describe the history of toxic epidermal necrolysis, before and after the original report by the British dermatologist Alan Lyell in 1956. Methods: Subjective expert choice of key advances in the comprehension of the nosology, classification, causality, and mechanisms of epidermal necrolysis (EN) over more than a century. Results: Epidermolysis had been reported long before Lyell's paper, but most cases had likely been staphylococcal scalded skin syndrome in children. Concerning non-Staphylococcus EN, confusion with erythema multiforme dissipated and its relation to Stevens Johnson syndrome was clarified. Tremendous advances were made in understanding the causes and mechanisms, with increased acceleration in the last 10 years. Conclusion: The next decade should be devoted to improve the prevention and management of a disease that is the most terrible form of drug hypersensitivity. Copyright (C) 2013, Taiwanese Dermatological Association. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 50 条
  • [31] Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Dobry, Allison S.
    Himed, Sonia
    Waters, Margo
    Kaffenberger, Benjamin H.
    FRONTIERS IN MEDICINE, 2022, 9
  • [32] Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study
    Elkarimi, M.
    Elrherbi, A.
    Filali, H.
    Hakkou, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 55 - 55
  • [33] Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jaller, Jose A.
    McLellan, Beth N.
    Balagula, Yevgeniy
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (01) : 58 - 72
  • [34] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [35] Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    Fagot, JP
    Mockenhaupt, M
    Bouwes-Bavinck, JN
    Naldi, L
    Viboud, C
    Roujeau, JC
    AIDS, 2001, 15 (14) : 1843 - 1848
  • [36] Diagnosis and management of Stevens-Johnson syndrome toxic epidermal necrolysis
    Noe, Megan H.
    Micheletti, Robert G.
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 607 - 612
  • [37] STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THE SETTING OF CIRRHOSIS
    Piechocki, S.
    Zamora, K.
    McCormick, A.
    Engel, L. S.
    Ward, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 728 - 728
  • [38] Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis in adults
    Lee, Haur Yueh
    Thirumoorthy, T.
    Lee, Haur Yueh
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB150 - AB150
  • [39] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lerch, Marianne
    Mainetti, Carlo
    Beretta-Piccoli, Benedetta Terziroli
    Harr, Thomas
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (01) : 147 - 176
  • [40] Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Saeed, Hajirah N.
    Chodosh, James
    SEMINARS IN OPHTHALMOLOGY, 2016, 31 (1-2) : 85 - 90